Huibert has a medical background and has extensive experience in medical innovation management. He has co-founded four companies that develop and bring to the market medical innovations. He has written protocols for, organized and served as medical officer in several international  clinical studies. He has also been involved in regulatory affairs, including orphan drug designations.